Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Saved in:
Bibliographic Details
Title: Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.
Authors: Pugh C; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA., Keasey S; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA., Korman L; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA., Pittman PR; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA., Ulrich RG; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA rulrich@bhsai.org.
Source: Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2014 Jun; Vol. 21 (6), pp. 877-85. Date of Electronic Publication: 2014 Apr 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101252125 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-679X (Electronic) Linking ISSN: 1556679X NLM ISO Abbreviation: Clin Vaccine Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-679X
DOI:10.1128/CVI.00035-14